Differential analysis of histopathological and genetic markers of cancer aggressiveness, and survival difference in EBV-positive and EBV-negative prostate carcinoma

Medicine and Dentistry

• Prostate Carcinoma 100%
• Malignant Neoplasm 100%
• Epstein Barr Virus 100%
• Genetic Marker 100%
• Lymphocytic Infiltration 25%
• Epithelial Mesenchymal Transition 25%
• Oncomir 15%
• Vimentin 10%
• Perineural Invasion 10%
• Oncogene 10%
• CD3 Antigen 10%
• Logistic Regression Analysis 5%
• Gene Expression Profiling 5%
• Stromal Tumor 5%
• Molecular Marker 5%
• B Cell 5%
• T Cell 5%
• Real-Time Polymerase Chain Reaction 5%
• Cost Benefit Analysis 5%
• Mir-145 5%
• microRNA 126 5%

Immunology and Microbiology

• Prostate 100%
• Genetic Marker 100%
• Epstein Barr Virus 100%
• CD3 Antigen 10%
• Oncogene 10%
• B Cell 5%
• Real-Time Polymerase Chain Reaction 5%
• Genetic Marker 5%
• T Cell 5%
• Gene Expression Assay 5%

Biochemistry, Genetics and Molecular Biology

• Epstein Barr Virus 100%
• Genetic Marker 100%
• Oncogene 10%
• Vimentin 10%
• Genetic Marker 5%
• Gene Expression Profiling 5%
• Real-Time Polymerase Chain Reaction 5%
• Mir-126 5%
• B Cell 5%
• T Cell 5%
• Mir-145 5%